These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 6846248)
1. Continuous vindesine infusion in advanced head and neck cancer. Popkin JD; Bromer RH; Vaughan CW; Byrne RE; Licciardello JT; Hoffer SM; Welch JM; Fofonoff SA; Strong MS; Hong WK Am J Clin Oncol; 1983 Jun; 6(3):301-4. PubMed ID: 6846248 [TBL] [Abstract][Full Text] [Related]
2. Phase II trial of vindesine in advanced squamous cell cancer of the head and neck. Vogl SE; Camacho FJ; Kaplan BH; O'Donnell MR Cancer Treat Rep; 1984 Mar; 68(3):559-60. PubMed ID: 6704987 [No Abstract] [Full Text] [Related]
3. Phase II trial of vindesine in advanced head and neck cancer. Cheng E; Young CW; Wittes RE Cancer Treat Rep; 1980; 64(10-11):1141-2. PubMed ID: 7459901 [TBL] [Abstract][Full Text] [Related]
4. Phase II trial of vindesine in patients with squamous cell cancer of the head and neck. Sledge GW; Clark GM; Griffin C; Mattox DE; Von Hoff DD Am J Clin Oncol; 1984 Jun; 7(3):209-11. PubMed ID: 6731343 [TBL] [Abstract][Full Text] [Related]
5. Vindesine in head and neck cancer. A Southwest Oncology Group Phase II pilot study. Haas CD; Fabian CJ; Stephens RL; Kish J Invest New Drugs; 1983; 1(4):339-40. PubMed ID: 6678881 [TBL] [Abstract][Full Text] [Related]
6. [Preliminary results of a chemotherapy study of patients with squamous cell carcinoma in the head and neck region. Comparison of 2 therapeutic regimens: cis-diamminodichloroplatinum (II) and bleomycin compared to methotrexate and vindesine]. von Heyden HW; Beyer JH; Matthaei A; Nagel GA; Schröder M Onkologie; 1981 Dec; 4(6):296-9. PubMed ID: 6175933 [TBL] [Abstract][Full Text] [Related]
7. A randomized study of continuous infusion vindesine versus vinblastine in adults with refractory metastatic sarcomas. Yap BS; Benjamin RS; Plager C; Burgess MA; Papadoupoulos N; Bodey GP Am J Clin Oncol; 1983 Apr; 6(2):235-8. PubMed ID: 6829497 [TBL] [Abstract][Full Text] [Related]
8. Vindesine in bronchogenic carcinoma: a phase II trial. Vogelzang NJ; Peterson BA; Kennedy BJ; Vosika GJ; Conroy JA Am J Clin Oncol; 1982 Feb; 5(1):41-4. PubMed ID: 6282107 [TBL] [Abstract][Full Text] [Related]
9. Cisplatin, vindesine, and 96-h continuous infusion of 5-fluorouracil as initial chemotherapy for locally advanced head and neck carcinoma. Perey L; Pasche P; Bauer J; Capasso P; Savary M; Leyvraz S Am J Clin Oncol; 1991 Apr; 14(2):162-5. PubMed ID: 2028924 [TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy of head and neck squamous cell cancer with vindesine (Eldesine) and cis-platinum (Platinex) (author's transl)]. Ruffmann R; Seifert R; Ross H; Sturm E Laryngol Rhinol Otol (Stuttg); 1982 Jul; 61(7):406-10. PubMed ID: 7202092 [TBL] [Abstract][Full Text] [Related]
11. A phase II study of cisplatin and continuous infusion of vindesine in metastatic head and neck squamous cell cancer. Tellez-Bernal E; Recondo G; Guillot T; Benhamed M; Domenge C; Izzo J; Cvitkovic E; Armand JP Cancer; 1990 Aug; 66(4):640-4. PubMed ID: 2386892 [TBL] [Abstract][Full Text] [Related]
12. [2d interim evaluation of a chemotherapy study on patients with squamous cell carcinomas of the head-neck area. A comparison of 2 therapy regimens: cis-diamminedichloroplatinum (II) and bleomycin versus methotrexate and vindesine]. Schröder M; von Heyden HW; Scherpe A; Borghardt J; Beyer JH; Nagel GA; Gerhartz H; Kastenbauer E; Westerhausen M; Schroeder M; Caliebe W; Rudert H; Lissers R; Hofmann J; Schneider B Onkologie; 1983 Jun; 6(3):114-7. PubMed ID: 6193472 [TBL] [Abstract][Full Text] [Related]
14. Initial clinical study with vindesine: tolerance to weekly iv bolus and 24-hour infusion. Ohnuma T; Greenspan EM; Holland JF Cancer Treat Rep; 1980 Jan; 64(1):25-30. PubMed ID: 6929728 [TBL] [Abstract][Full Text] [Related]
15. [Cytostatic therapy of advanced squamous cell carcinoma of the head and neck. A randomized study comparing cis-dichlorodiammineplatinum(II) and bleomycin with methotrexate and vindesine]. von Heyden HW; Schröder M; Scherpe A; Beyer JH; Kaboth U; Stennert E; Nagel GA; Gerhartz H; Foth B; Kastenbauer E Onkologie; 1984 Jun; 7(3):183-90. PubMed ID: 6205337 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of epidermoid head and neck cancer with cisplatinum/bleomycin vs methotrexate/vindesine]. Schröder M; von Heyden HW; Beyer JH; Klee M Laryngol Rhinol Otol (Stuttg); 1981 Jun; 60(6):331-3. PubMed ID: 6167831 [TBL] [Abstract][Full Text] [Related]
17. Phase II trial of ICRF-187 in squamous cell carcinoma of the head and neck. Wheeler RH; Bricker LJ; Natale RB; Baker SR Cancer Treat Rep; 1984 Feb; 68(2):427-8. PubMed ID: 6421483 [TBL] [Abstract][Full Text] [Related]
18. [Vindesine in oral cancers]. Szpirglas H; Marneur M; Vaillant JM Presse Med; 1985 Feb; 14(7):405-7. PubMed ID: 3157128 [TBL] [Abstract][Full Text] [Related]
19. Chemotherapy of squamous head and neck cancer: a prospective randomized trial comparing cis-platinum and bleomycin with methotrexate and vindesine. von Heyden HW; Schröder M; Scherpe A; Borghardt J; Beyer JH; Nagel GA; Gerhartz H; Foth B; Kastenbauer E; Westerhausen M Recent Results Cancer Res; 1985; 98():148-52. PubMed ID: 2412266 [No Abstract] [Full Text] [Related]
20. A comparison of vindesine administration by bolus injection and by 24-hour infusion. Gilby ED Cancer Treat Rev; 1980 Sep; 7 Suppl 1():47-51. PubMed ID: 7438121 [No Abstract] [Full Text] [Related] [Next] [New Search]